AVTRECLIV
Live / Applied — First extension granted (statement of use) (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 21 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99013357
- Mark type
- Stylized text
- Filed
- 21 Jan 2025
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2026 — SOU EXTENSION 1 GRANTED
- 05 Mar 2026 — SOU EXTENSION 1 FILED
- 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE